Objective: This study was designed to comparatively analyse the response and survival between Carboplatin plus Paclitaxel (TP) vs. 5FU plus Epirubicin plus Cyclophosphamide (FEC) in ER, PR and HER-2 neu negative Breast Cancer patients of locally advanced breast cancer (LABC), lar...
Open access
Research Article10.9734/JCTI/2018/46585
Satadru Biswas, Bidisha Bandyopadhyay, Hambir Chowdhury, Kuntal Ray, Debanti Banerjee, Ritam Joarder, Souvik Paul, Debapriya Mondal, Sukanta Chakraborty & Chhaya Roy·Journal of Cancer and Tumor International·2018
Inflammatory Myofibroblastic Tumour (IMT) is a rare entity which constitutes 0.04–1.2% of all lung tumours. Though IMT was first described as an ‘Interesting Benign Lung Tumour’, recurrence, the discovery of cytogenetic aberrations, a clonal population of cells and oncogenic prot...
Open access
Research Article10.9734/JCTI/2018/39255
Solid Pseudopapillary Tumour (SPPT) of the pancreas are rare tumours, accounting for only 1-2% of all pancreatic neoplasms. Increased rate of detection of this neoplasm in the last three decades is probably due to the increased awareness and the increased provision of imaging. Th...
Open access
Research Article10.9734/IJMPCR/2017/37962
Introduction: In a tribal population based area in West Bengal, India though carcinoma cervix is the commonest malignancy in female patients, yet apart from that carcinoma breast is also increasing in number in the recent years. Breast cancer accounts for approximately 26.6% of f...
Open access
Research Article10.9734/jcti/2019/v9i130100
The majority of oral cavity cancers presents as localized disease and remain localized until late in the course of their development. Distant metastasis is very rare in carcinoma of buccal mucosa and has a very dismal prognosis. Distant spread is either related to uncontrolled lo...
Open access
Research Article10.9734/IJMPCR/2017/32368